Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-26 @ 1:57 AM
Study NCT ID:
NCT01094405
Status:
COMPLETED
Last Update Posted:
2021-07-28
First Post:
2010-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Sponsor:
Chinese University of Hong Kong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-26
First Submit QC Date:
None
Study First Post Date:
2010-03-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-26
Last Update Post Date:
2021-07-28
Last Update Post Date Type:
ACTUAL